Stacy Lindborg - 07 Dec 2022 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
Co-Chief Executive Officer
Signature
/s/ Stacy Lindborg
Issuer symbol
BCLI
Transactions as of
07 Dec 2022
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 06:36:29 UTC
Previous filing
15 Jun 2022
Next filing
21 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Award $0 +35,000 +140% $0.000000 60,000 07 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of December 7, 2022, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date.